Ozempic Could Soon Be Cheaper in US

Getting your hands on the drug that everyone has been talking about may be about to get easier.
Ozempic, the semaglutide injection made by pharma company Novo Nordisk, is predicted to have its price cut in negotiations with the U.S. government.
The drug, which is designed to help patients with type 2 diabetes manage blood sugar levels, is currently priced at nearly $1,000 a month in the U.S.
Ozempic dose. The type 2 diabetes drug, which can also cause weight loss, may be about to get cheaper. Ozempic dose. The type 2 diabetes drug, which can also cause weight loss, may be about to get cheaper. ISTOCK / GETTY IMAGES PLUS